Determination of human serum 8-hydroxy-2'-deoxyguanosine (8-OHdG) by HPLC-ECD combined with solid phase extraction (SPE).

Human serum 8-hydroxy-2'-deoxyguanosine (8-OHdG) was measured by HPLC-ECD method combined with solid phase extraction (SPE) developed by our group: (our proprietary kit, named 8-OHdG Pre-treatment Kit (TANITA Corporation)). The major interfering substances and proteins in serum were removed by 8-OHdG Pre-treatment Kit. This measurement method was highly reproducible (CV=2.2-7.1%) and demonstrated the lower detection limit for control serum sample of less than 10 pg/ml without the sample evaporation. The other hand 8-OHdG concentration in serum for healthy people was in the range of 0-70 pg/ml (25.5+/-13.8 pg/ml, n=37). Secondary a relationship between the HPLC-ECD and ELISA methods was investigated. ELISA method could not detect 8-OHdG concentration in serum for healthy people, because the detection limit of 130 pg/ml was higher than the normal range for healthy people. These results show our SPE method has high sensitivity and quantitative accuracy for 8-OHdG analysis.

[1]  M. Källberg,et al.  Determination of urinary 8-hydroxydeoxyguanosine by automated coupled-column high performance liquid chromatography: a powerful technique for assaying in vivo oxidative DNA damage in cancer patients. , 1995, European journal of cancer.

[2]  Brian Crow,et al.  A simple and cost effective method for the quantification of 8-hydroxy-2'-deoxyguanosine from urine using liquid chromatography tandem mass spectrometry. , 2008, Biomedical chromatography : BMC.

[3]  H. Moriwaki.  Determination of 8-Hydroxy-2′-deoxyguanosine in Urine by Liquid Chromatography–Electrospray Ionization–Mass Spectrometry , 2000 .

[4]  M. Beal,et al.  A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2'-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods. , 1999, Free radical biology & medicine.

[5]  B. Halliwell,et al.  Can oxidative DNA damage be used as a biomarker of cancer risk in humans? Problems, resolutions and preliminary results from nutritional supplementation studies. , 1998, Free radical research.

[6]  G. Scherer,et al.  Fast quantification of the urinary marker of oxidative stress 8-hydroxy-2'-deoxyguanosine using solid-phase extraction and high-performance liquid chromatography with triple-stage quadrupole mass detection. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[7]  S. Toyokuni,et al.  Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. , 1999, Diabetes.

[8]  H. Rüdiger,et al.  Assay for the determination of urinary 8-hydroxy-2'-deoxyguanosine by high-performance liquid chromatography with electrochemical detection. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[9]  T. Ohe,et al.  Elevated levels of oxidative DNA damage in serum and myocardium of patients with heart failure. , 2006, Circulation Journal.

[10]  M. Kawana,et al.  Significance of 8-hydroxy-2'-deoxyguanosine levels in patients with idiopathic dilated cardiomyopathy. , 2006, Journal of cardiac failure.

[11]  B. Ames,et al.  Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Kamohara,et al.  Oxidative DNA damage (8-hydroxydeoxyguanosine) and body iron status: a study on 2507 healthy people. , 2003, Free radical biology & medicine.

[13]  T. Inoue,et al.  Immunological response to oxidized LDL occurs in association with oxidative DNA damage independently of serum LDL concentrations in dyslipidemic patients. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[14]  P. Mecocci,et al.  Oxidative damage to DNA in lymphocytes from AD patients , 1998, Neurology.

[15]  F. Cardozo-Pelaez,et al.  Assessing biomarkers of oxidative stress: analysis of guanosine and oxidized guanosine nucleotide triphosphates by high performance liquid chromatography with electrochemical detection. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[16]  Louis W. Chang,et al.  Clinical-scale high-throughput analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine by isotope-dilution liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction. , 2006, Clinical chemistry.

[17]  P. Wilairat,et al.  Quantitative determination of 8-hydroxy-2′-deoxyguanosine as a biomarker of oxidative stress in thalassemic patients using HPLC with an electrochemical detector , 2008 .

[18]  F. Violante,et al.  A method for routine quantitation of urinary 8-hydroxy-2'-deoxyguanosine based on solid-phase extraction and micro-high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.

[19]  H. Yamato,et al.  Urea, the most abundant component in urine, cross-reacts with a commercial 8-OH-dG ELISA kit and contributes to overestimation of urinary 8-OH-dG. , 2009, Free radical biology & medicine.

[20]  Choon Nam Ong,et al.  A high-throughput and sensitive methodology for the quantification of urinary 8-hydroxy-2'-deoxyguanosine: measurement with gas chromatography-mass spectrometry after single solid-phase extraction. , 2004, The Biochemical journal.

[21]  Dong Chang,et al.  Oxidative damage to DNA and its relationship with diabetic complications. , 2007, Biomedical and environmental sciences : BES.

[22]  C. Lengger,et al.  A high-performance liquid chromatographic method for the determination of 8-oxo-7,8-dihydro-2'-deoxyguanosine in urine from man and rat. , 2000, Analytical biochemistry.

[23]  Y. Hsueh,et al.  Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area. , 2008, Toxicology and applied pharmacology.

[24]  B. Ames,et al.  Assay of excised oxidative DNA lesions: isolation of 8-oxoguanine and its nucleoside derivatives from biological fluids with a monoclonal antibody column. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  F. Sichel,et al.  Measurement of 8-Hydroxy-2′-Deoxyguanosine by a Commercially Available ELISA Test: Comparison with HPLC/Electrochemical Detection in Calf Thymus DNA and Determination in Human Serum , 2003 .

[26]  M. Catani,et al.  Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. , 2002, Archives of neurology.

[27]  D. V. van Thiel,et al.  Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection. , 1999, Free radical biology & medicine.

[28]  Y. Ogawa,et al.  Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine values measured by an ELISA correlated well with measurements by high-performance liquid chromatography with electrochemical detection. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  N. Vermeulen,et al.  Simultaneous determination of tyrosine, phenylalanine and deoxyguanosine oxidation products by liquid chromatography-tandem mass spectrometry as non-invasive biomarkers for oxidative damage. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[30]  M. Beal,et al.  Increased oxidative damage to DNA in ALS patients. , 2000, Free radical biology & medicine.